Mwandishi
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
Jumatano, 15 Julai 2026, 2:43:25 GMT +3
Antituberculosis Medicines lists
Antituberculosis Medicines lists
Name of drug | Dosage forms and Strengths | Level of medicine |
Ethambutol | Tablet (as hydrochloride) 400mg | A |
Ethambutol+Isoniazide | Tablet 400mg + 100mg | A |
Ethionamide | Tablet 125mg, 250mg | S |
Isoniazid | Tablet 100mg | A |
Pyrazinamide | Tablet 500mg | A |
Rifampicin+Isoniazid | Capsule/Tablet,150mg+75mg, 50mg+150mg | A |
Rifampicin+Isoniazid+Pyrazinamid e+Ethambutol | Tablet 150mg + 75mg + 400mg + 275mg | A |
Reserved Second-line for Treatment of Multidrug Resistance Tuberculosis (MDR-TB)
Name of drug | Dosage forms and Strengths | Level of medicine |
Cycloserine | Tablet 250mg | S |
Bedaquiline | Tablet 100mg | S |
Capromycine | Powder for injection 1g (as sulfate) in a vial | S |
Delamanide | Tablet 50mg | S |
Kanamycin | Powder for injection: 1g (as sulfate) in vial | S |
Levofloxacin | Tablet 250mg | S |
Linezolid | Injection for intravenous administration: 2mg/mL in 300mL bag; Tablet 400mg; 600mg | S |
Moxifloxacin | Tablet 400mg | S |
p-Amino salicylic acid (PAS) | Granules 4g in a sachet; Tablet 500mg | S |
Imeandikwa:
Jumatano, 3 Juni 2026, 18:22:47 GMT +3
References: